Medicare Enrolled
Dr. Elizabeth Byron, M.D.
Hematology · Palm Springs, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Byron from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Byron?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Byron
Dr. Elizabeth Byron is a hematology specialist in Palm Springs, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Byron performed 143,968 Medicare services across 3,603 unique beneficiaries.
Between the years covered by Open Payments, Dr. Byron received a total of $7,313 from 66 pharmaceutical and/or device companies across 413 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Byron is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 37% volume in FL
$7,313 industry payments
Medicare Practice Summary
Medicare Utilization ↗143,968
Medicare services
Top 37% in FL for hematology
3,603
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,469 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 31,620 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 22,920 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 20,200 | $40 | $137 |
| Paclitaxel chemotherapy injection | 18,070 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 12,090 | $1 | $5 |
| Iron sucrose injection (Venofer) | 9,230 | $0 | $5 |
| Contrast dye for imaging (iodine-based) | 5,970 | $0 | $1 |
| Immune globulin infusion (Gammagard) | 5,120 | $36 | $108 |
| Denosumab injection (Prolia/Xgeva) | 3,300 | $18 | $51 |
| Complete blood count (CBC) with differential | 2,466 | $8 | $29 |
| Blood draw (venipuncture) | 2,123 | $8 | $9 |
| Dexamethasone injection (steroid) | 1,919 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,310 | $1 | $28 |
| Office visit, established patient (20-29 min) | 1,257 | $69 | $239 |
| Office visit, established patient (30-39 min) | 987 | $99 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 748 | $0 | $9 |
| Injection of additional new drug or substance into vein | 479 | $12 | $61 |
| Drug injection, under skin or into muscle | 476 | $11 | $69 |
| Administration of chemotherapy into vein, 1 hour or less | 441 | $102 | $378 |
| Injection, carboplatin, 50 mg | 424 | $2 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 249 | $50 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 223 | $22 | $84 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 223 | $1 | $6 |
| Administration of additional new drug or substance into vein, 1 hour or less | 208 | $51 | $178 |
| Administration of chemotherapy into vein, each additional hour | 193 | $23 | $79 |
| Injection, diphenhydramine hcl, up to 50 mg | 174 | $1 | $3 |
| Infusion into a vein for hydration, each additional hour | 170 | $10 | $42 |
| Infusion, normal saline solution , 1000 cc | 146 | $2 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 134 | $25 | $156 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 127 | $16 | $56 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 93 | $1 | $7 |
| Red blood count, automated test | 87 | $4 | $10 |
| Injection, magnesium sulfate, per 500 mg | 84 | $1 | $2 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 73 | $398 | $680 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 70 | $1,166 | $3,706 |
| New patient office visit, complex (60-74 min) | 70 | $175 | $585 |
| Automated urinalysis | 66 | $2 | $8 |
| Ct scan of chest with contrast | 64 | $54 | $344 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 62 | $3 | $11 |
| Injection of drug or substance into vein | 58 | $29 | $156 |
| CT scan of abdomen and pelvis with contrast | 55 | $180 | $550 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 50 | $4 | $15 |
| New patient office visit (45-59 min) | 48 | $130 | $453 |
| Hospital follow-up visit, moderate complexity | 25 | $65 | $197 |
| Echocardiogram, transthoracic | 22 | $101 | $435 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 16 | $15 | $56 |
| CT scan of chest, without contrast | 14 | $47 | $350 |
| Initial hospital admission, high complexity | 14 | $142 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.3% high complexity
68.5% medium
5.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,313
Total received (2018-2024)
Avg $1,045/year across 7 years
Bottom 49% in FL for hematology
66
Companies
413
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,301 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,915
2023
$1,236
2022
$1,463
2021
$503
2020
$517
2019
$742
2018
$937
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$1,223
Novartis Pharmaceuticals Corporation
$779
Celgene Corporation
$452
PFIZER INC.
$372
E.R. Squibb & Sons, L.L.C.
$348
AstraZeneca Pharmaceuticals LP
$326
GlaxoSmithKline, LLC.
$279
Pharmacyclics LLC, An AbbVie Company
$261
Genentech USA, Inc.
$248
ABBVIE INC.
$216
Eisai Inc.
$205
Tempus AI, Inc
$190
Daiichi Sankyo Inc.
$185
Incyte Corporation
$160
GENZYME CORPORATION
$136
Seagen Inc.
$116
Bayer Healthcare Pharmaceuticals Inc.
$113
Astellas Pharma US Inc
$89
Pharmacyclics LLC, an AbbVie Company
$88
Heron Therapeutics, Inc.
$82
Amgen Inc.
$82
ARRAY BIOPHARMA INC
$69
EMD Serono, Inc.
$68
Bayer HealthCare Pharmaceuticals Inc.
$66
Blueprint Medicines Corporation
$62
Boehringer Ingelheim Pharmaceuticals, Inc.
$58
NanoString Technologies, Inc.
$58
BeiGene USA, Inc.
$58
Merck Sharp & Dohme Corporation
$53
Dendreon Pharmaceuticals LLC
$53
Lilly USA, LLC
$51
SANOFI-AVENTIS U.S. LLC
$48
Takeda Pharmaceuticals U.S.A., Inc.
$45
Otsuka America Pharmaceutical, Inc.
$41
Ipsen Biopharmaceuticals, Inc
$40
Rigel Pharmaceuticals, Inc.
$33
Seattle Genetics, Inc.
$32
Aurobindo Pharma USA, Inc.
$30
Sumitomo Pharma America, Inc.
$29
Octapharma USA, Inc.
$28
Janssen Scientific Affairs, LLC
$25
TESARO, Inc.
$23
Pharmacosmos Therapeutics Inc.
$23
Clovis Oncology, Inc.
$21
SERVIER PHARMACEUTICALS LLC
$20
Foundation Medicine, Inc.
$20
Helsinn Therapeutics (U.S.), Inc.
$19
Genmab U.S., Inc.
$19
Taiho Oncology, Inc.
$19
CTI BioPharma Corp.
$19
Mirati Therapeutics, Inc.
$19
PharmaEssentia USA Corporation
$19
Sirtex Medical Inc
$18
Array BioPharma Inc.
$18
Adaptive Biotechnologies Corporation
$18
TG THERAPEUTICS, INC.
$17
MEDIVATION FIELD SOLUTIONS LLC
$16
EUSA Pharma (US) LLC
$16
GE HealthCare
$15
Agios Pharmaceuticals, Inc.
$14
Merck Sharp & Dohme LLC
$14
Innate Pharma, Inc
$14
Kite Pharma, Inc.
$13
Gilead Sciences, Inc.
$12
NOVARTIS PHARMACEUTICALS CORPORATION
$6
Veracyte, Inc.
$4
Top 3 companies account for 33.6% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · AUGTYRO · AYVAKIT · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Braftovi · CALQUENCE · CARVYKTI · CINVANTI · CYRAMZA · Cerianna · DARZALEX · ELAHERE · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · Enhertu · Epkinly · FOUNDATIONONE · Folotyn · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · LYNPARZA · Lenvima · Lumoxiti · MEKINIST · MONOFERRIC · NINLARO · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · REBLOZYL · RYBREVANT · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · Stivarga · Sylvant · TABRECTA · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TUKYSA · Tibsovo · UKONIQ · VENCLEXTA · VERZENIO · VOTRIENT · Vonjo · XALKORI · XOSPATA · XT CDX · XTANDI · Xofigo · Yescarta · ZEJULA · Zevalin · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $5 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
11
Per 100K population
0.7
County median income
$81,115
Nearest hospital
HCA FLORIDA JFK HOSPITAL
3.2 mi
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Byron is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Byron experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Byron performed 31,620 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Byron receive payments from pharmaceutical companies?
Yes. Dr. Byron received a total of $7,313 from 66 companies across 413 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Byron's costs compare to other hematologists in Palm Springs?
Dr. Byron's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Byron) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Palm Springs
Browse hematologists in Palm Springs ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology